Xeris Biopharma Holdings reported cash from operations of $8.26M and free cash flow of $8.26M for the quarter ended Jun 2026. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||
| Net Income | -26.01M | -50.79M | -33.71M | -26.18M | -21.83M | -12.93M | -16.83M | -19.84M | -12.19M | -13.39M | -18.98M | -15.01M | -15.74M | -5.11M | -9.22M | -1.93M | 0.62M | 11.08M | 2.23M | -31.10M | ||||
| Share-based CompensationStock Comp. | 3.67M | 2.74M | 3.30M | 2.77M | 2.56M | 20.04M | 2.77M | 3.77M | 4.23M | 6.77M | 3.60M | 8.00M | 1.45M | 7.64M | 5.27M | 17.02M | 0.19M | |||||||
| Deferred Taxes | 0.06M | -0.14M | -0.15M | -1.19M | -0.68M | 0.68M | -1.25M | 0.31M | 0.75M | -3.32M | ||||||||||||||
| Gains from Investment SecuritiesGains Investment | -0.08M | 0.79M | ||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -22.61M | -28.95M | -48.41M | -20.61M | -17.75M | -16.12M | -26.14M | -13.74M | -14.61M | 7.47M | -20.30M | -10.35M | -8.30M | 1.98M | -10.03M | 0.18M | 18.43M | 20.04M | 9.87M | 8.26M | ||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | -0.07M | -0.06M | -0.05M | -0.08M | -0.02M | 0.57M | 0.38M | 0.43M | 0.30M | 0.15M | 0.18M | 0.30M | 0.19M | 0.07M | 0.12M | 0.13M | 0.14M | 0.15M | 0.16M | 0.18M | ||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.20M | 0.27M | 0.22M | 0.50M | 0.40M | 0.49M | 0.55M | 0.60M | 0.60M | 0.51M | 0.60M | 0.80M | 0.80M | 0.81M | 0.84M | 0.80M | 0.80M | 0.89M | 0.90M | 0.90M | ||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.32M | 0.35M | 0.32M | 0.35M | 0.36M | 0.37M | 0.36M | 0.39M | 0.39M | 0.35M | 0.33M | 0.28M | 0.31M | 0.31M | 0.32M | 0.33M | 0.34M | 0.34M | 0.34M | 0.32M | ||||
| Change in Working Capital | ||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 1.27M | -0.45M | 5.93M | 2.37M | 1.76M | 3.31M | 0.03M | -0.64M | 15.74M | -6.77M | -1.78M | 5.03M | -1.30M | -0.72M | 5.92M | 6.72M | 0.70M | -2.70M | 5.25M | 1.81M | ||||
| Change in InventoryChange Inventory | 1.26M | 2.27M | 0.16M | 0.15M | 1.66M | 5.50M | 3.82M | 7.43M | 2.15M | 1.40M | 2.33M | 2.27M | 1.05M | 3.14M | 3.62M | 7.57M | 4.08M | 4.01M | -0.85M | 9.50M | ||||
| Change in Account PayablesChange Payables | -0.90M | 4.35M | 2.17M | -4.46M | -2.71M | 0.69M | 6.93M | 0.08M | 0.30M | -0.35M | -4.47M | -1.59M | 1.65M | -5.20M | 4.06M | -4.43M | 2.00M | -1.70M | 4.25M | 0.29M | ||||
| Change in Accured ExpensesChange Accured Exp. | 4.07M | 7.91M | -13.66M | 1.18M | 0.34M | 0.75M | -13.93M | 2.73M | -0.80M | 6.15M | -1.12M | 2.95M | 0.47M | 1.35M | -8.58M | 5.35M | 4.62M | 2.33M | -4.68M | 1.67M | ||||
| Investing Activities | ||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.13M | |||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 29.45M | 10.50M | 6.70M | 12.10M | 6.88M | 9.30M | 10.00M | 15.00M | 15.00M | 5.00M | 10.00M | 15.00M | 10.24M | |||||||||||
| Cash from Investing ActivitiesCash from Investing | 18.50M | 36.60M | 6.72M | 11.87M | 6.71M | 9.17M | -43.98M | 8.45M | 14.65M | 14.87M | -19.65M | 4.60M | 9.91M | 10.02M | -0.01M | -0.28M | -0.07M | -0.33M | -0.33M | -0.21M | ||||
| Financing Activities | ||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.27M | 0.01M | 0.50M | 0.32M | 0.55M | 0.46M | 0.25M | 0.53M | 4.86M | 0.97M | 5.16M | 0.58M | 7.33M | 0.60M | ||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.00M | 0.12M | 78.19M | 0.31M | -0.19M | 49.16M | -0.86M | 0.56M | -0.07M | -1.23M | 35.19M | 0.66M | -0.08M | 0.40M | -3.14M | 0.94M | 13.85M | -0.27M | -8.84M | 1.94M | ||||
| Change in Capital Stock | ||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 30.00M | |||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.00M | -0.00M | -0.00M | 0.00M | ||||||||||||||||||||
| Change in Cash | -4.11M | 7.78M | 36.50M | -8.43M | -11.23M | 42.20M | -70.98M | -4.74M | -0.03M | 21.11M | -4.76M | -5.09M | 1.53M | 12.39M | -13.18M | 0.84M | 32.21M | 19.44M | 0.71M | 10.00M | ||||
| Free Cash FlowFCF | -22.61M | -29.08M | -48.41M | -20.61M | -17.75M | -16.12M | -26.14M | -13.74M | -14.61M | 7.47M | -20.30M | -10.35M | -8.30M | 1.98M | -10.03M | 0.18M | 18.43M | 20.04M | 9.87M | 8.26M | ||||
| Net Cash FlowNCF | -4.11M | 7.78M | 36.50M | -8.43M | -11.23M | 42.20M | -70.98M | -4.74M | -0.03M | 21.11M | -4.76M | -5.09M | 1.53M | 12.39M | -13.18M | 0.84M | 32.21M | 19.44M | 0.71M | 10.00M |